{"organizations": [], "uuid": "7afb3893a673d348bbe0414a1d7021f5d70ec80c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.i360gov.com", "main_image": "", "site_section": "http://feeds.feedburner.com/FederalGovernmentNewsRss-I360Gov", "section_title": "Government Policy, Business and Technology: i360 Gov", "url": "http://www.i360gov.com/government-health-IT-news/2015/oct/09/f-d-a-approval-of-oxycontin-for-children-continues-to-draw-scrutiny", "country": "US", "title": "F.D.A. Approval of OxyContin for Children Continues to Draw Scrutiny", "performance_score": 0, "site": "i360gov.com", "participants_count": 0, "title_full": "F.D.A. Approval of OxyContin for Children Continues to Draw Scrutiny", "spam_score": 0.0, "site_type": "news", "published": "2015-10-09T14:06:00.000+03:00", "replies_count": 0, "uuid": "7afb3893a673d348bbe0414a1d7021f5d70ec80c"}, "author": "", "url": "http://www.i360gov.com/government-health-IT-news/2015/oct/09/f-d-a-approval-of-oxycontin-for-children-continues-to-draw-scrutiny", "ord_in_thread": 0, "title": "F.D.A. Approval of OxyContin for Children Continues to Draw Scrutiny", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "09 F.D.A. Approval of OxyContin for Children Continues to Draw Scrutiny \nThe New York Times: Ever since the Food and Drug Administration approved the use of the narcotic painkiller OxyContin for certain children in August, it has faced unabated criticism from lawmakers and public officials who are wrestling with devastating rates of prescription opioid abuse in their communities. Last week, Hillary Rodham Clinton brought the issue to the presidential race, calling the agency’s action “absolutely incomprehensible.”", "external_links": [], "published": "2015-10-09T14:06:00.000+03:00", "crawled": "2015-10-10T01:06:12.268+03:00", "highlightTitle": ""}